tetraethylammonium has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellis, A | 1 |
| Pannirselvam, M | 1 |
| Anderson, TJ | 1 |
| Triggle, CR | 1 |
| Rastelli, VM | 1 |
| Oliveira, MA | 1 |
| dos Santos, R | 1 |
| de Cássia Tostes Passaglia, R | 1 |
| Nigro, D | 1 |
| de Carvalho, MH | 1 |
| Fortes, ZB | 1 |
| Williams, BA | 1 |
| Smith, PA | 1 |
| Leow, K | 1 |
| Shimizu, S | 1 |
| Gray, DW | 1 |
| Ashcroft, FM | 1 |
3 other studies available for tetraethylammonium and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Catalase has negligible inhibitory effects on endothelium-dependent relaxations in mouse isolated aorta and small mesenteric artery.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Apamin; Cardiovascular Agents; Catalase; Charybdotoxin; Dia | 2003 |
Lack of potentiation of bradykinin by angiotensin-(1-7) in a type 2 diabetes model: role of insulin.
Topics: Angiotensin I; Animals; Animals, Newborn; Blood Glucose; Bradykinin; Diabetes Mellitus, Type 2; Drug | 2007 |
Two types of potassium channel regulated by ATP in pancreatic B cells isolated from a type-2 diabetic human.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adult; Diabetes Mellitus, Type 2; Electric Conductivi | 1993 |